Pravastatin: Difference between revisions
imported>Robert Badgett No edit summary |
mNo edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
{{Image|Pravastatin structure.jpg|right|350px|Pravastatin, a class I statin.}} | |||
'''Pravastatin''', or pravastatina (Spanish), pravastatin sodium, pravastatine (French) or pravastatinum (Latin), is an [[Antilipemic agent|Antilipemic]] [[medication]]. It is a class I [[statin]] used to treat [[hypercholesterolemia]] (high cholesterol) and prevent [[myocardial infarction|heart attacks]] and stroke and diminish [[athlerosclosis]]. It is similar in structure and function to the other class I statins [[mevastatin]], [[lovastatin]] and [[simvastatin]]. It is an antilipemic fungal metabolite isolated from ''Nocardia autotrophica''. It is a competitive hydroxymethylglutaryl COA reductase (HMG CoA reductase) inhibitor. Unlike lovastatin and simvastatin, it is an active compound without prior hydrolysis due to its increased hydrophilicity. Inhibition of HNG CoA reductases results in increased clearance of circulating LDL. Pravastatin also inhibits hepatic synthesis of VLDL, the precursor for LDL, reducing circulating cholesterol and LDL cholesterol. | '''Pravastatin''', or pravastatina (Spanish), pravastatin sodium, pravastatine (French) or pravastatinum (Latin), is an [[Antilipemic agent|Antilipemic]] [[medication]]. It is a class I [[statin]] used to treat [[hypercholesterolemia]] (high cholesterol) and prevent [[myocardial infarction|heart attacks]] and stroke and diminish [[athlerosclosis]]. It is similar in structure and function to the other class I statins [[mevastatin]], [[lovastatin]] and [[simvastatin]]. It is an antilipemic fungal metabolite isolated from ''Nocardia autotrophica''. It is a competitive hydroxymethylglutaryl COA reductase (HMG CoA reductase) inhibitor. Unlike lovastatin and simvastatin, it is an active compound without prior hydrolysis due to its increased hydrophilicity. Inhibition of HNG CoA reductases results in increased clearance of circulating LDL. Pravastatin also inhibits hepatic synthesis of VLDL, the precursor for LDL, reducing circulating cholesterol and LDL cholesterol. | ||
| Line 23: | Line 23: | ||
==External links== | ==External links== | ||
{{CZMed}} | {{CZMed}}[[Category:Suggestion Bot Tag]] | ||
Latest revision as of 11:01, 6 October 2024
Pravastatin, or pravastatina (Spanish), pravastatin sodium, pravastatine (French) or pravastatinum (Latin), is an Antilipemic medication. It is a class I statin used to treat hypercholesterolemia (high cholesterol) and prevent heart attacks and stroke and diminish athlerosclosis. It is similar in structure and function to the other class I statins mevastatin, lovastatin and simvastatin. It is an antilipemic fungal metabolite isolated from Nocardia autotrophica. It is a competitive hydroxymethylglutaryl COA reductase (HMG CoA reductase) inhibitor. Unlike lovastatin and simvastatin, it is an active compound without prior hydrolysis due to its increased hydrophilicity. Inhibition of HNG CoA reductases results in increased clearance of circulating LDL. Pravastatin also inhibits hepatic synthesis of VLDL, the precursor for LDL, reducing circulating cholesterol and LDL cholesterol.
Its IUPAC chemical name is (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid and its chemical formula is C23H36O7.
Brand names
- Compactin
- Elisor
- Lipostat
- Mevalotin
- Mevastatin
- Mevinolin
- Oliprevin
- Pravachol
- Pravaselect
- Selectin
- Selipran
- Vasten
External links
The most up-to-date information about Pravastatin and other drugs can be found at the following sites.
- Pravastatin - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Pravastatin - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Pravastatin - Detailed information from DrugBank.